Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(16/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(16/week)
News
United States
(600/week)
Manufacturing
(427/week)
Energy
(314/week)
Technology
(448/week)
Other Manufacturing
(344/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Anti–vascular endothelial growth factor therapy
Apr 22, 2020
REGENXBIO Announces Additional Positive Long-term and Interim Phase I/IIa Trial Update for RGX-314 for the Treatment of Wet AMD
Mar 16, 2020
Kodiak Sciences Announces Fourth Quarter and Full Year 2019 Financial Results and Recent Business Highlights
Mar 02, 2020
Proliferative Diabetic Retinopathy Industry Insights, 2020-2025 - Key Players are Novartis, Regeneron Pharma, Allergan, Roche, Oxurion, Alimera Sciences, BCN Peptides, Glycadia Pharma and Kowa Group
Mar 02, 2020
Proliferative Diabetic Retinopathy Industry Insights, 2020-2025 - Key Players are Novartis, Regeneron Pharma, Allergan, Roche, Oxurion, Alimera Sciences, BCN Peptides, Glycadia Pharma and Kowa Group
Feb 05, 2020
Kodiak Sciences Announces Upcoming Presentation of Additional KSI-301 Phase 1b Clinical Study Data at Angiogenesis, Exudation, and Degeneration 2020 Meeting
Dec 02, 2019
Kodiak Sciences Announces Sale of Future Royalties on KSI-301 for $225 Million to Baker Bros. Advisors
Oct 22, 2019
U.S. Food & Drug Administration Approves New Wet Age-Related Macular Degeneration Treatment
Oct 11, 2019
REGENXBIO Announces Additional Positive Interim Phase I/IIa Trial Update for RGX-314 for the Treatment of Wet AMD at the American Academy of Ophthalmology 2019 Annual Meeting
Oct 10, 2019
Kodiak Sciences Treats First Patients in DAZZLE Pivotal Study of KSI-301 in Wet Age-Related Macular Degeneration
Oct 03, 2019
Allergan to Showcase Late-Stage Data in Age-Related Macular Degeneration and Glaucoma at American Academy of Ophthalmology Annual Meeting
Oct 01, 2019
LumiThera Enrolls First Patient in the U.S. Multi-Center, LIGHTSITE III Clinical Study to Treat Dry Age-Related Macular Degeneration
Sep 15, 2019
Kodiak Sciences Announces Emerging Durability Data from Ongoing Phase 1b Study of KSI-301 in Wet AMD Patients at The Retina Society Annual Meeting
May 30, 2019
REGENXBIO Announces Completion of Dosing for Phase I/IIa Clinical Trial of RGX-314 in Wet AMD
May 07, 2019
REGENXBIO Reports First Quarter 2019 Financial and Operating Results and Additional Positive Interim Phase I/IIa Trial Update for RGX-314 for the Treatment of Wet AMD
Apr 17, 2019
Innovent Announces First Patient Dosed in a Phase I Clinical Trial of IBI302 for the Treatment of Wet AMD
Apr 11, 2019
LumiThera Announces First Patient Enrollment in the European Multi-Center, LIGHTSITE II Clinical Study to Treat Dry Age-Related Macular Degeneration
Apr 02, 2019
Allergan and Molecular Partners Announce Topline Safety Results from MAPLE study of Abicipar pegol
Mar 25, 2019
Alkahest Presents Positive Results from Phase 2a Open Label Study of AKST4290 in Treatment-Naïve neovascular AMD at Retina World Congress
Feb 26, 2019
LumiThera Receives Notice of Award for $2.5 Million National Eye Institute Grant to Support U.S. Multi-Center Clinical Trial for Treating Dry Age-Related Macular Degeneration
Dec 21, 2018
Kodiak Sciences Announces Completion of 12-Week Phase 1a Study of KSI-301 in Patients with Diabetic Macular Edema Demonstrating Safety and Durability of Responses Following Single Dose of Intravitreal Anti-VEGF Antibody Biopolymer Conjugate
Page 1
››
Latest News
Apr 26, 2024
Kyocera Announces Consolidated Financial Results for Year Ended March 31, 2024
Apr 26, 2024
Mitsubishi Electric Announces Consolidated Financial Results for Fiscal 2024
Apr 26, 2024
Peugeot Sport Aims for the Endurance Racing Finish Line With Simulation From Dassault Systèmes
Apr 26, 2024
Orbia Announces First Quarter 2024 Financial Results
Apr 26, 2024
Metro Storage LLC Invests in Sustainable Future with Rooftop Solar Energy Panels
Apr 26, 2024
Freeport-McMoRan Publishes 2023 Annual Report on Sustainability
Apr 26, 2024
SJW Group Announces First Quarter 2024 Financial Results
Apr 26, 2024
Resolutions Adopted at the Annual General Ordinary and Extraordinary Shareholders’ Meeting for Grupo...
View all News
Agenda
24
September
Hilton London Syon Park, London, UK
Defence Transformation Conference
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
View All Events